These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 7647332)

  • 1. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S; Lévesque C; Geng CS; Yan X; Labrie F
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Labrie F; Li S; Labrie C; Lévesque C; Mérand Y
    Breast Cancer Res Treat; 1995 Mar; 33(3):237-44. PubMed ID: 7749151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
    Li S; Martel C; Dauvois S; Bélanger A; Labrie F
    Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y; Schneider MR; Michna H
    J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
    Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
    Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
    Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
    Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.
    Dauvois S; Geng CS; Lévesque C; Mérand Y; Labrie F
    Cancer Res; 1991 Jun; 51(12):3131-5. PubMed ID: 2039992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S; Spinola PG; Labrie F
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
    Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
    J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).
    Luo S; Labrie C; Bélanger A; Candas B; Labrie F
    Breast Cancer Res Treat; 1998 May; 49(1):1-11. PubMed ID: 9694606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
    Labrie F; Kelly PA; Asselin J; Raynaud JP
    Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
    Nguyen BL; Chetrite G; Pasqualini JR
    Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
    Martel C; Sourla A; Pelletier G; Labrie C; Fournier M; Picard S; Li S; Stojanovic M; Labrie F
    J Endocrinol; 1998 Jun; 157(3):433-42. PubMed ID: 9691976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.